Approval · Notice of Compliance 21428 · 2018
ANAFRANIL: Notice of Compliance 21428
Issued October 16, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21428
- Date
- October 16, 2018
- Company
- AA Pharma Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Reformulatio of anafranil includint a change in manufacturing, packaging, labelling and quality control sites
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ANAFRANIL | Not yet assigned | — |
Medicinal ingredients
- CLOMIPRAMINE HCL 10 MG per TAB